A detailed history of New York State Common Retirement Fund transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 13,100 shares of FULC stock, worth $43,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,100
Previous 25,100 47.81%
Holding current value
$43,492
Previous $156,000 69.87%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$3.18 - $9.74 $38,160 - $116,880
-12,000 Reduced 47.81%
13,100 $47,000
Q2 2024

Jul 31, 2024

BUY
$5.98 - $9.31 $150,098 - $233,681
25,100 New
25,100 $156,000
Q2 2023

Aug 07, 2023

SELL
$2.26 - $3.8 $34,955 - $58,774
-15,467 Reduced 97.63%
376 $1,000
Q1 2023

May 02, 2023

SELL
$2.83 - $13.99 $7,983 - $39,465
-2,821 Reduced 15.11%
15,843 $45,000
Q4 2022

Jan 30, 2023

BUY
$5.01 - $8.35 $20 - $33
4 Added 0.02%
18,664 $136,000
Q3 2022

Nov 08, 2022

BUY
$4.92 - $9.1 $516 - $955
105 Added 0.57%
18,660 $151,000
Q2 2022

Aug 04, 2022

SELL
$4.2 - $24.0 $193 - $1,104
-46 Reduced 0.25%
18,555 $91,000
Q1 2022

May 05, 2022

BUY
$9.96 - $23.65 $159 - $378
16 Added 0.09%
18,601 $440,000
Q4 2021

Feb 02, 2022

SELL
$14.0 - $28.44 $182 - $369
-13 Reduced 0.07%
18,585 $329,000
Q3 2021

Nov 02, 2021

BUY
$7.28 - $30.97 $45,048 - $191,642
6,188 Added 49.86%
18,598 $525,000
Q2 2021

Aug 02, 2021

BUY
$8.09 - $12.0 $1,156 - $1,716
143 Added 1.17%
12,410 $130,000
Q2 2020

Aug 07, 2020

BUY
$9.11 - $22.06 $59,214 - $143,390
6,500 Added 112.71%
12,267 $224,000
Q3 2019

Nov 07, 2019

BUY
$6.64 - $14.89 $38,292 - $85,870
5,767 New
5,767 $38,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $173M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.